MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-19-2026
Aeglea BioTherapeutics Depreciation & Amortization 2011-2026 | AGLE
Annual Depreciation & Amortization Aeglea BioTherapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 744 K | 1.57 M | 1.58 M | 996 K | 418 K | 293 K | 249 K | 132 K | 89 K | 19 K | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.58 M | 19 K | 608 K |
Quarterly Depreciation & Amortization Aeglea BioTherapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | 384 K | - | 1.18 M | - | 403 K | - | 1.16 M | - | 355 K | - | 627 K | 376 K | 154 K | - | 312 K | 207 K | 100 K | - | 221 K | 145 K | 70 K | - | 183 K | 114 K | 52 K | - | 96 K | 62 K | 29 K | - | 60 K | 35 K | 17 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.18 M | 17 K | 276 K |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aligos Therapeutics
ALGS
|
930 K | $ 8.65 | 8.19 % | $ 85.5 M |  USA |
 |
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M |  China |
 |
AlloVir
ALVR
|
13 K | - | 4.14 % | $ 49.1 M | USA |
 |
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | USA |
 |
Esperion Therapeutics
ESPR
|
105 K | $ 2.14 | -1.38 % | $ 445 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
31.6 M | $ 20.47 | 0.49 % | $ 957 M | USA |
 |
GT Biopharma
GTBP
|
4 K | $ 0.36 | -2.82 % | $ 1.98 M | USA |
 |
Acorda Therapeutics
ACOR
|
31.7 M | - | -24.86 % | $ 820 K | USA |
 |
Halozyme Therapeutics
HALO
|
11.4 M | $ 67.06 | -1.12 % | $ 8.04 B | USA |
 |
Adverum Biotechnologies
ADVM
|
3.65 M | - | - | $ 86.2 M | USA |
 |
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
100 K | - | -10.17 % | $ 12.2 K | USA |
 |
Harmony Biosciences Holdings
HRMY
|
23.8 M | $ 28.69 | -0.69 % | $ 1.65 B | USA |
 |
Akebia Therapeutics
AKBA
|
1.27 M | $ 1.41 | 0.71 % | $ 363 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | USA |
 |
Allakos
ALLK
|
6.14 M | - | - | $ 28.6 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
24 K | $ 2.96 | 1.37 % | $ 4.87 M |  Israel |
 |
Aptinyx
APTX
|
122 K | - | -39.0 % | $ 4.57 M | USA |
 |
Aquestive Therapeutics
AQST
|
548 K | $ 4.16 | 1.84 % | $ 445 M | USA |
 |
Aravive
ARAV
|
886 K | - | -13.39 % | $ 1.45 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
700 K | $ 24.01 | -0.85 % | $ 3.05 B | USA |
 |
ImmuCell Corporation
ICCC
|
2.78 M | $ 7.12 | 1.14 % | $ 64.3 M | USA |
 |
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | USA |
 |
Celldex Therapeutics
CLDX
|
3.38 M | $ 32.24 | - | $ 2.14 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
8.3 M | $ 1.48 | -0.67 % | $ 394 M |  Britain |
 |
Aptose Biosciences
APTO
|
22 K | - | -45.71 % | $ 1.2 M | Canada |
 |
Cidara Therapeutics
CDTX
|
154 K | - | - | $ 1.41 B | USA |
 |
Incyte Corporation
INCY
|
93.3 M | $ 94.86 | -1.26 % | $ 18.5 B | USA |
 |
AVROBIO
AVRO
|
617 K | - | 1083.1 % | $ 745 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
5.38 M | $ 2.61 | 2.35 % | $ 16.4 M | USA |